The MDMA Therapy Training Program is currently supporting the final segment of training for Phase 3 Therapy Teams. Supervision is the focus of active Phase 2 open-label trials in the U.S. and Canada, and will continue to be an important aspect of the training program going forward. As therapy pairs treat their first study participant, they receive feedback through regular supervision meetings. Supervisors are expert MDMA-assisted psychotherapy researchers. With the help of trained Adherence Raters, Supervisors review video recordings of therapy sessions. The careful review of recorded therapy sessions informs a Supervisor’s guidance to therapy pairs in the application of knowledge gained in training and improvement of treatment outcomes. There are 3 Supervisors and 12 Adherence Raters currently supporting 40 new Therapy Pairs in open-label trials in the U.S. and Canada. Learn more…